X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (285) 285
mitotane (210) 210
female (201) 201
male (184) 184
index medicus (154) 154
mitotane - therapeutic use (154) 154
mitotane - administration & dosage (147) 147
adult (132) 132
middle aged (131) 131
adrenal cortex neoplasms - drug therapy (129) 129
animals (117) 117
adrenocortical carcinoma (109) 109
cancer (94) 94
endocrinology & metabolism (91) 91
oncology (86) 86
adrenocortical carcinoma - drug therapy (81) 81
adrenal-cortical carcinoma (78) 78
aged (66) 66
adrenal cortex neoplasms - pathology (64) 64
mitotane - adverse effects (63) 63
treatment outcome (63) 63
dogs (62) 62
antineoplastic combined chemotherapy protocols - therapeutic use (61) 61
antineoplastic agents, hormonal - therapeutic use (57) 57
adrenal cortex neoplasms - surgery (55) 55
cushing syndrome - drug therapy (54) 54
adolescent (52) 52
tumors (52) 52
chemotherapy (49) 49
adrenocortical carcinoma - pathology (47) 47
veterinary sciences (47) 47
prognosis (45) 45
mitotane - pharmacology (43) 43
carcinoma (42) 42
therapy (42) 42
antineoplastic agents, hormonal - administration & dosage (41) 41
surgery (41) 41
adrenalectomy (39) 39
hydrocortisone - blood (39) 39
cisplatin - administration & dosage (37) 37
dose-response relationship, drug (37) 37
retrospective studies (37) 37
adrenal cortex neoplasms - mortality (35) 35
carcinoma - drug therapy (35) 35
adrenal cortex neoplasms - diagnosis (34) 34
dog diseases - drug therapy (33) 33
adrenal cortex neoplasms - therapy (32) 32
etoposide - administration & dosage (32) 32
cisplatin (31) 31
adrenocortical hyperfunction - veterinary (30) 30
o,p'-ddd (30) 30
adrenocortical carcinoma - surgery (29) 29
chemotherapy, adjuvant (29) 29
management (29) 29
medicine & public health (29) 29
adjuvant mitotane (28) 28
combined modality therapy (28) 28
endocrinology (28) 28
pharmacology & pharmacy (28) 28
doxorubicin (27) 27
time factors (27) 27
adrenocortical hyperfunction - drug therapy (26) 26
dosage and administration (26) 26
doxorubicin - administration & dosage (26) 26
etoposide (26) 26
follow-up studies (26) 26
abridged index medicus (25) 25
cortisol (25) 25
phase-ii trial (25) 25
adrenocortical carcinoma - diagnosis (24) 24
adrenocortical carcinoma - therapy (24) 24
analysis (24) 24
care and treatment (24) 24
child (24) 24
diagnosis (24) 24
metastasis (24) 24
mitotane - blood (24) 24
survival rate (24) 24
health aspects (23) 23
young adult (23) 23
adrenal gland neoplasms - drug therapy (22) 22
adrenocortical carcinoma - mortality (22) 22
pituitary-dependent hyperadrenocorticism (22) 22
series (21) 21
survival (21) 21
tomography, x-ray computed (21) 21
antineoplastic agents, hormonal - adverse effects (20) 20
disease-free survival (20) 20
drug therapy, combination (20) 20
neoplasm staging (20) 20
adrenal glands (19) 19
long-term survival (19) 19
research (19) 19
survival analysis (19) 19
adrenal cortex neoplasms - metabolism (18) 18
cushings-syndrome (18) 18
adrenal glands - drug effects (17) 17
adrenocortical carcinoma - metabolism (17) 17
antineoplastic agents - therapeutic use (17) 17
antineoplastic agents, hormonal - pharmacology (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (382) 382
Russian (20) 20
French (11) 11
German (7) 7
Japanese (7) 7
Polish (2) 2
Danish (1) 1
Serbian (1) 1
Spanish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 23, pp. 2189 - 2197
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4551 - 4564
Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing attention during the last decade. Here we provide an update on advances in... 
GROWTH-FACTOR RECEPTOR | POSITRON-EMISSION-TOMOGRAPHY | LAPAROSCOPIC ADRENALECTOMY | CANCER-PATIENTS | STEROIDOGENIC FACTOR-1 | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | PHASE-II | ADJUVANT RADIOTHERAPY | BETA-CATENIN | PROGNOSTIC VALUE | Adrenal Glands - pathology | Lymph Node Excision | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Adrenocortical Carcinoma - surgery | Humans | Adrenocortical Carcinoma - diagnosis | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Neoplasm Proteins - antagonists & inhibitors | Molecular Targeted Therapy | Neoplasm Proteins - metabolism | Mitotane - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Adrenal Cortex Neoplasms - diagnosis | Adrenocortical Carcinoma - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adrenocortical Carcinoma - metabolism | Chemotherapy, Adjuvant | Adrenal Glands - drug effects | Mitotane - administration & dosage | Adrenal Cortex Neoplasms - metabolism | Antineoplastic Agents, Hormonal - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Adrenal Cortex Neoplasms - surgery | Adrenal Glands - surgery | Mitotane - therapeutic use | Adrenal Cortex Neoplasms - drug therapy | Animals | Adrenal Glands - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Decision Trees | Neoplasm Staging
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 2014, Volume 21, Issue 3, pp. 383 - 394
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 10/2016, Volume 23, Issue 10, pp. 825 - 837
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 426 - 435
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 06/2010, Volume 17, Issue 2, pp. 445 - 453
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2013, Volume 98, Issue 12, pp. 4759 - 4767
Context: Mitotane is the only approved drug for treatment of adrenocortical carcinoma. Its pharmacokinetic properties are not fully elucidated and different... 
METABOLITES | THERAPY | PLASMA | PHARMACOLOGY | O,P'-DDD | ENDOCRINOLOGY & METABOLISM | MONITORED MITOTANE | O,P'DDD | CYP3A4 | CANCER | CLINICAL MANAGEMENT | Dichlorodiphenyl Dichloroethylene - blood | Adrenal Cortex Neoplasms - blood | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Gastrointestinal Diseases - physiopathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Adrenal Cortex - pathology | Antineoplastic Agents, Hormonal - pharmacokinetics | Dose-Response Relationship, Drug | Adrenocortical Carcinoma - pathology | Antineoplastic Agents, Hormonal - adverse effects | Adrenocortical Carcinoma - drug therapy | Drug Interactions | Antineoplastic Agents, Hormonal - therapeutic use | Biotransformation | Adult | Female | Adrenal Cortex - drug effects | Mitotane - administration & dosage | Severity of Illness Index | Adrenocortical Carcinoma - secondary | Antineoplastic Agents, Hormonal - administration & dosage | Mitotane - adverse effects | Adrenal Cortex Neoplasms - pathology | Mitotane - therapeutic use | Mitotane - pharmacokinetics | Adrenal Cortex Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neurotoxicity Syndromes - physiopathology | Adrenocortical Carcinoma - blood | Drug Monitoring | Neoplasm Staging | Gastrointestinal Diseases - chemically induced | Phenylacetates - blood
Journal Article
Journal Article
Anti-Cancer Drugs, ISSN 0959-4973, 07/2017, Volume 28, Issue 6, pp. 634 - 644
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 07/2017, Volume 24, Issue 7, pp. 299 - 307
Journal Article
Hormones and Cancer, ISSN 1868-8497, 8/2014, Volume 5, Issue 4, pp. 232 - 239
Journal Article
Journal Article